Gainers
- Arbutus Biopharma Corporation (NASDAQ:ABUS) climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down Moderna's appeal to invalidate two of Arbutus' patents on drug-delivery technology used in the former's COVID-19 vaccine.
- OceanPal Inc. (NASDAQ:OP) shares climbed 51.3% to $7.90 after completion of spinoff from Diana Shipping on Tuesday.
- Advanced Human Imaging Limited (NASDAQ:AHI) surged 39% to $4.3201 following circulation of apparent co. press release dated Dec. 1: 'Advanced Human Imaging concludes Definitive agreements with Canadian based Cubert.'
- Context Therapeutics Inc. (NASDAQ:CNTX) rose 37.7% to $9.48 after jumping 23% on Tuesday.
- MDJM Ltd (NASDAQ:MDJH) jumped 32.3% to $3.48.
- Build-A-Bear Workshop, Inc. (NYSE:BBW) surged 32.3% to $22.57 after the company reported better-than-expected Q3 results and raised FY21 guidance. The company also announced a special dividend and a share buyback.
- Ardelyx, Inc. (NASDAQ:ARDX) gained 24.5% to $1.42 after Citigroup raised its price target on the stock $7 to $13.
- Ambarella, Inc. (NASDAQ:AMBA) shares gained 23.4% to $221.46 after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.
- Stronghold Digital Mining, Inc. (NASDAQ:SDIG) gained 21.5% to $20.95 after the company announced better-than-expected Q3 sales results.
- Roivant Sciences Ltd. (NASDAQ:ROIV) jumped 18.1% to $7.83. Roivant Sciences, last month, posted a Q2 loss of $0.32 per share.
- Stran & Company, Inc. (NASDAQ:STRN) surged 19.3% to $4.20.
- BriaCell Therapeutics Corp. (NASDAQ:BCTX) rose 18% to $11.63 following Seeking Alpha blogpost from contributor 'AAA Investments' 'Why BCTX Is Undervalued - PT $30+.'
- Marpai, Inc. (NASDAQ:MRAI) gained 16.7% to $4.48.
- Sensus Healthcare, Inc. (NASDAQ:SRTS) gained 16.5% to $7.16 after the company announced the signing of an exclusive U.S. distribution agreement with Mattioli Eng. Italia for its TransDermal Infusion System non-invasive drug delivery system.
- Quotient Limited (NASDAQ:QTNT) jumped 15.8% to $2.4550. Quotient named Mr. Esteban Uriarte as the Company’s Chief Manufacturing Operations Officer.
- Cyngn Inc. (NASDAQ:CYN) surged 14.3% to $6.03.
- PetVivo Holdings, Inc. (NASDAQ:PETV) rose 13.7% to $3.2992.
- ImmunoGen, Inc. (NASDAQ:IMGN) gained 13% to $6.98 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $7 to $12. ImmunoGen announced proposed public offering of $175 million of common stock.
- Box, Inc. (NYSE:BOX) shares rose 12.2% to $26.27 after the company reported better-than-expected Q3 results and issued EPS guidance. The company also increased its buyback to $700 million.
- Skylight Health Group Inc. (NASDAQ:SLHG) gained 12.1% to $1.4795 after dipping around 10% on Tuesday. Skylight Health Group, last month, posted a Q3 net loss of $3.9 million.
- Molecular Templates, Inc. (NASDAQ:MTEM) surged 11.5% to $4.47. Molecular Templates provided corporate update and outlined 2022 milestones.
- Zogenix, Inc. (NASDAQ:ZGNX) gained 11% to $12.49. The FDA has granted Priority Review to Zogenix’s supplemental marketing application seeking approval for Fintepla (fenfluramine) in Lennox-Gastaut syndrome (LGS) childhood-onset epilepsy.
- Five Point Holdings, LLC (NYSE:FPH) rose 9.8% to $5.92.
- Birks Group Inc. (NYSE:BGI) gained 9.6% to $4.5499.
- Landec Corporation (NASDAQ:LNDC) rose 8.8% to $8.65.
- The Goodyear Tire & Rubber Company (NASDAQ:GT) gained 8.6% to $21.85
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Check out these big penny stock gainers and losers
Losers
- BeyondSpring Inc. (NASDAQ:BYSI) shares dipped 55.7% to $5.66 after the company announced the FDA issued a Complete Response Letter related to the company's plinabulin New Drug Application. HC Wainwright & Co. downgraded BeyondSpring from Buy to Neutral.
- Aditxt, Inc. (NASDAQ:ADTX) shares fell 25.2% to $0.8746 after reporting a proposed public offering of common stock and warrants.
- Pioneer Power Solutions, Inc. (NASDAQ:PPSI) dipped 23.8% to $7.70.
- Biofrontera Inc. (NASDAQ:BFRI) fell 22.4% to $4.6481. Biofrontera recently posted Q3 loss of $2.00 per share.
- AeroClean Technologies, Inc. (NASDAQ:AERC) dropped 22.2% to $19.45.
- CTI BioPharma Corp. (NASDAQ:CTIC) fell 21.6% to $1.7650 after the company said the FDA has extended the review period for the new drug application for pacritinib for the treatment of adult patients with intermediate or high-risk primary or secondary myelofibrosis with a baseline platelet count of less than 50 × 109/L.
- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) fell 21.4% to $3.9517. Cumberland Pharmaceuticals shares jumped 128% on Tuesday after the company announced the FDA approved expanded labeling for Caldolor to now include use in pre-operative administration.
- NuZee, Inc. (NASDAQ:NUZE) fell 20.4% to $3.70.
- Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) dropped 16.7% to $2.38. Petros Pharmaceuticals recently announced a 3.33 million share offering at $3 per share.
- Aptevo Therapeutics Inc. (NASDAQ:APVO) fell 15.6% to $8.40.
- Longeveron Inc. (NASDAQ:LGVN) fell 15.2% to $22.28 after the company announced a private placement of approximately $20.5 million of its common stock and warrants.
- Allbirds, Inc. (NASDAQ:BIRD) dropped 15.1% to $16.33 after reporting a wider quarterly loss.
- ThredUp Inc. (NASDAQ:TDUP) fell 13.7% to $16.15.
- Arteris, Inc. (NASDAQ:AIP) dropped 13.7% to $23.43. Arteris reported a Q3 loss of $0.21per share.
- iSpecimen Inc. (NASDAQ:ISPC) fell 12.6% to $16.14.
- GBS Inc. (NASDAQ:GBS) fell 10.6% to $1.77. GBS shares gained 22% on Tuesday after the company announced it will commence preparation for clinical trials of its rapid SARS-CoV-2 Antibody test following the recent successful completion of a clinical validation study.
- NLS Pharmaceutics AG (NASDAQ:NLSP) fell 10.1% to $1.8250. NLS Pharmaceuticals shares gained 16% on Tuesday after the company announced final results from a preclinical study for NLS-4. The company believes NLS-4 offers promise to become a foundational treatment for the chronic fatigue associated with the symptoms of Long-Covid.
- Sweetgreen, Inc. (NYSE:SG) dipped 10% to $34.35.
- 8x8, Inc. (NYSE:EGHT) fell 9.7% to $19.44. 8x8 announced plans to buy Fuze in $250 million in stock and cash.
- Moderna, Inc. (NASDAQ:MRNA) fell 9.6% to $318.55 after The Patent Trial and Appeals Board turned down the company's appeal to invalidate two of Arbutus' patents on drug-delivery technology. The stock has been volatile amid COVID-19 omicron variant concerns.
- Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) fell 9.1% to $5.20. Clarus Therapeutics shares jumped 10% on Tuesday after the company announced issuance of two new patents for JATENZO.
- Invacare Corporation (NYSE:IVC) dropped 8.8% to $2.4975. Invacare announced realignment of EMEA & APAC Businesses.
- salesforce.com, inc. (NYSE:CRM) shares fell 7.5% to $263.70. salesforce reported upbeat results for its third quarter, but issued weak forecast.
- Guardforce AI Co., Limited. (NASDAQ:GFAI) shares fell 6.8% to $1.6217. Guardforce AI Co shares gained 20% on Tuesday after the company announced it won a five year bid to operate a Consolidated Cash Center in Hadyai, Thailand.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.